☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Gilead Initiates Two P-III Studies Evaluating Remdesivir (GS-5734) for COVID-19 in the UK
April 2, 2020
Merck & Co. Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-177 Study for Advanced Microsatellite Instability-Hig...
April 2, 2020
Vir and Alnylam Expand Their Existing Collaboration to Develop RNAi Therapeutics Targeting Host Factors for COVID-19
April 2, 2020
Three Global Pharmaceutical Companies Launch Worker Volunteer Programs to Combat COVID-19
April 2, 2020
Y-mAbs Reports the Submission of Naxitamab's BLA to the US FDA for Relapsed/Refractory High-Risk Neuroblastoma
April 2, 2020
FDA Launches Emergency Program to Expedite the Development of COVID-19 Treatments
April 2, 2020
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions